Jungjin Ahn, the CFO and co-founder of Prazer Therapeutics, brings extensive experience in corporate finance, operations management, and strategic planning to the company. She has a diverse and accomplished background in global business development, corporate development, investment, and M&A, with notable experience at major IT companies like SKT. Throughout her career, Jungjin has led strategic initiatives that have driven corporate growth and global expansion, including managing high-value mergers and acquisitions. Her expertise also extends to venture capital, where she has been instrumental in funding innovative startups and supporting entrepreneurial ventures. With multiple startup experiences, Jungjin combines financial expertise with hands-on operational leadership. Her broad experience across various sectors has enabled her to effectively manage PRazer’s financial strategy, investor relations, and global partnerships, positioning the company for long-term success in the biotech industry.